Koninklijke Philips (NYSE:PHG – Get Free Report) will announce its earnings results before the market opens on Monday, July 29th. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Koninklijke Philips (NYSE:PHG – Get Free Report) last issued its earnings results on Monday, April 29th. The technology company reported $0.28 earnings per share for the quarter. Koninklijke Philips had a positive return on equity of 9.82% and a negative net margin of 4.41%. The business had revenue of $4.49 billion for the quarter. On average, analysts expect Koninklijke Philips to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Koninklijke Philips Price Performance
PHG stock opened at $25.76 on Friday. The company has a market cap of $24.21 billion, a PE ratio of -26.83, a price-to-earnings-growth ratio of 0.95 and a beta of 0.72. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58. The stock has a 50-day moving average price of $26.26 and a two-hundred day moving average price of $23.45. Koninklijke Philips has a 12-month low of $17.75 and a 12-month high of $29.44.
Koninklijke Philips Cuts Dividend
Wall Street Analysts Forecast Growth
Several research analysts recently commented on PHG shares. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a report on Tuesday, April 30th. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a research report on Monday, May 13th. BNP Paribas raised Koninklijke Philips from an “underperform” rating to a “neutral” rating in a research report on Tuesday, May 7th. JPMorgan Chase & Co. raised Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research report on Tuesday, April 30th. Finally, StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also
- Five stocks we like better than Koninklijke Philips
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Call Options Volume for These 2 Stocks Spiked Together
- Ride Out The Recession With These Dividend Kings
- MarketBeat Week in Review – 7/22 – 7/26
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.